Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.

ABSTRACT:

Objective

To examine survival of women who develop metachronous uterine malignancy after definitive pelvic radiotherapy for cervical cancer.

Methods

This retrospective observational study examined the Surveillance, Epidemiology, End Results Program between 1973 and 2013. Women with cervical cancer who received definitive radiotherapy without hysterectomy were examined for the diagnosis of metachronous uterine malignancy (n = 5277). Survival was compared between metachronous and non-metachronous uterine malignancies according to tumor factors.

Results

The 10- and 20-year cumulative incidences of metachronous uterine malignancy were 0.6% and 1.2%, respectively. When compared to non-metachronous uterine malignancy, metachronous tumor were more likely to be non-endometrio

SUBMITTER: Matsuo K 

PROVIDER: S-EPMC7521081 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature